Bank Of America Corp Moderna, Inc. Put Options Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

Put Options

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$63.64 - $125.14 $789,136 - $1.55 Million	-12,400 Reduced 20.81%	47,200 $3.15 Million
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $3.11 Million - $5.11 Million	30,700 Added 106.23%	59,600 $7.08 Million
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $1.94 Million - $2.62 Million	22,700 Added 366.13%	28,900 $3.08 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $3.82 Million - $5.74 Million	-55,000 Reduced 89.87%	6,200 $616,000
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $17.4 Million - $23.5 Million	-146,500 Reduced 70.53%	61,200 $7.44 Million
Q1 2023 May 12, 2023	SELL	$135.66 - $197.02 $56.8 Million - $82.4 Million	-418,400 Reduced 66.83%	207,700 $31.9 Million
Q4 2022 Feb 10, 2023	SELL	$118.38 - $210.04 $53.4 Million - $94.7 Million	-450,800 Reduced 41.86%	626,100 $112 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $44 Million - $72.4 Million	-373,000 Reduced 25.73%	1,076,900 $127 Million
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $20.2 Million - $30.5 Million	-172,500 Reduced 10.63%	1,449,900 $207 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $115 Million - $213 Million	-906,900 Reduced 35.86%	1,622,400 $279 Million
Q4 2021 Feb 08, 2022	SELL	$225.82 - $368.51 $45.9 Million - $74.9 Million	-203,300 Reduced 7.44%	2,529,300 $642 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $4.88 Million - $10.7 Million	22,000 Added 0.81%	2,732,600 $1.05 Billion
Q2 2021 Sep 13, 2021	BUY	$129.91 - $234.98 $352 Million - $637 Million	2,710,600 New	2,710,600 $637 Million

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account